CK Life Sciences International (Holdings), Inc. (0775.HK) stock price, financials & research

Regular session · HKT · Market data may be delayed.

Company profile

CK Life Sciences International (Holdings), Inc. operates as an investment company, which engages in the business of research and development, manufacturing, commercialization, marketing and selling of products and assets in nutraceuticals, pharmaceuticals and agriculture related business. It operates through the following segments: Agriculture-Related and Health. The company was founded on August 10, 2001 and is headquartered in Hong Kong.

Industry: Biotechnology
Sector: Healthcare
Headquarters: HK
CEO: Ying Choi Yu
Listed since: Jul 16, 2002
Employees: 1,920

Market position

Day range

Current HK$0.585

HK$0.58HK$0.61

52-week range

Current HK$0.585

HK$0.53HK$1.08

Open: HK$0.605
Previous close: HK$0.605
Volume: 2.19M; 0.69× average
Average volume: 3.16M; Average daily volume
Market cap: 5.62B HKD
Beta: 0.46; Market reference 1
50-day average: HK$0.5888; -0.65% below average
200-day average: HK$0.7414; -21.09% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value: 13.9B HKD
P/E (TTM): -87.31×
P/B (TTM): 1.42×
P/S (TTM): 1.02×
EV / EBITDA: -281.27×
Earnings yield: -2.39%
Free cash flow yield: -3.52%
Dividend yield: 0.00%

Profitability & efficiency

Gross margin: 13.39%
Operating margin: -0.21%
Net margin: -1.20%
Return on equity: -4.99%
Return on assets: -1.59%
Return on invested capital: -1.25%

Financial health

Debt / equity: 1.73×
Current ratio: 0.87×
Altman Z-score: 1.5
Piotroski F-score: 2 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin

Income trends

Revenue

5.41B HKD-2.04%

Operating income

−135.28M HKD−918.33M HKD

Net income

−188.45M HKD-48.91%

Metric (HKD)	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	5.41B HKD	5.52B HKD	5.32B HKD	5.28B HKD	5.4B HKD
Cost of goods sold	4.62B HKD	3.83B HKD	3.69B HKD	3.65B HKD	3.77B HKD
Gross profit	785.39M HKD	1.69B HKD	1.64B HKD	1.63B HKD	1.63B HKD
Research and development	320.61M HKD	254.1M HKD	145.87M HKD	158.54M HKD	157.27M HKD
Selling, general, and administrative	600.05M HKD	195.17M HKD	578.67M HKD	138.07M HKD	553.16M HKD
Operating expenses	920.66M HKD	909.5M HKD	724.54M HKD	1.38B HKD	728.83M HKD
Interest income	21.2M HKD	13.9M HKD	13.18M HKD	5.78M HKD	1.43M HKD
Interest expense	266.89M HKD	337.18M HKD	322.43M HKD	163.09M HKD	97.82M HKD
Depreciation and amortization	85.86M HKD	91.71M HKD	233.74M HKD	101.58M HKD	114.29M HKD
Operating income	−135.28M HKD	783.06M HKD	223.85M HKD	219.51M HKD	233.69M HKD
Net income	−188.45M HKD	−126.55M HKD	17.25M HKD	131.96M HKD	162.8M HKD

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result: -0.01

EPS: actual versus estimate

Recent quarterly results

ActualEstimate

Estimates unavailable

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate

Estimates unavailable

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

HK$0.008

2023 complete year-20.0% since 2019

HK$0.01

2,019

HK$0.01

2,020

HK$0.01

2,021

HK$0.01

2,022

HK$0.008

2,023

Corporate action history

Action	Ex-dividend date	Details	Record date	Payment date
Dividend	May 23, 2023	HK$0.008Annual	May 24, 2023	Jun 5, 2023
Dividend	May 20, 2022	HK$0.01Annual	May 23, 2022	Jun 1, 2022
Dividend	May 18, 2021	HK$0.01Annual	May 20, 2021	May 31, 2021
Dividend	May 19, 2020	HK$0.01Annual	May 20, 2020	May 29, 2020
Dividend	May 21, 2019	HK$0.01Annual	May 22, 2019	May 31, 2019
Dividend	May 15, 2018	HK$0.01Annual	May 16, 2018	May 28, 2018